The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.

Contract research organization Toxikon provides nonclinical testing services for pharma, biotech and medtech companies, supporting their safety and efficacy studies of new drugs and devices. (Labcorp) ...

Labcorp Holdings (NYSE: LH) partnered with Waters Corporation to deploy the BD Onclarity HPV Assay across its national ...

Labcorp said Friday it has struck a deal to buy Millennium Health, an accredited specialty laboratory. Financial terms were not disclosed. Millennium offers testing services to help clinicians monitor ...

Laboratory Corporation of America Holdings (LH) ("LabCorp") is an impressive business that played a crucial role throughout the pandemic. Returns on Equity have been in the low double-digit to ...

Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...

Labcorp, one of the country's largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test ...

Laboratory Corporation of America Holdings, or LabCorp LH, is gaining from strength in its Drug Development business. The company’s strong fourth-quarter performance instils optimism. However, stiff ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American ...